Adam H Bauer1, Jeff Bonham2, Luis Gutierrez2, Edward C Hsiao3, Daria Motamedi2. 1. Kaiser Fontana Medical Center, Fontana, CA, USA. adam.herman.bauer@gmail.com. 2. Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. 3. Division of Endocrinology, Diabetes, and Metabolism and the Institute for Human Genetics, Department of Medicine, University of California, San Francisco, CA, USA.
Abstract
OBJECTIVE: Fibrodysplasia ossificans progressiva is a rare genetic disorder characterized by congenital skeletal deformities and soft tissue masses that progress to heterotopic ossification. Deformities of the great toes are distinctive, and heterotopic ossification in the soft tissues follows an expected anatomic and temporal pattern. In addition to heterotopic ossification, osteochondromata, middle ear ossification, demyelination, lymphedema, and venous thrombosis are characteristic. Awareness of this constellation of findings is important to early diagnosis and surveillance. CONCLUSIONS: Recognition of the imaging manifestations of fibrodysplasia ossificans progressiva is imperative to early diagnosis in order to appropriately direct patient care and preclude unnecessary biopsies or surgical procedures.
OBJECTIVE:Fibrodysplasia ossificans progressiva is a rare genetic disorder characterized by congenital skeletal deformities and soft tissue masses that progress to heterotopic ossification. Deformities of the great toes are distinctive, and heterotopic ossification in the soft tissues follows an expected anatomic and temporal pattern. In addition to heterotopic ossification, osteochondromata, middle ear ossification, demyelination, lymphedema, and venous thrombosis are characteristic. Awareness of this constellation of findings is important to early diagnosis and surveillance. CONCLUSIONS: Recognition of the imaging manifestations of fibrodysplasia ossificans progressiva is imperative to early diagnosis in order to appropriately direct patient care and preclude unnecessary biopsies or surgical procedures.
Authors: R B Cohen; G V Hahn; J A Tabas; J Peeper; C L Levitz; A Sando; N Sando; M Zasloff; F S Kaplan Journal: J Bone Joint Surg Am Date: 1993-02 Impact factor: 5.284
Authors: Frederick S Kaplan; Meiqi Xu; Petra Seemann; J Michael Connor; David L Glaser; Liam Carroll; Patricia Delai; Elisabeth Fastnacht-Urban; Stephen J Forman; Gabriele Gillessen-Kaesbach; Julie Hoover-Fong; Bernhard Köster; Richard M Pauli; William Reardon; Syed-Adeel Zaidi; Michael Zasloff; Rolf Morhart; Stefan Mundlos; Jay Groppe; Eileen M Shore Journal: Hum Mutat Date: 2009-03 Impact factor: 4.878
Authors: Gregory K Deirmengian; Nader M Hebela; Michael O'Connell; David L Glaser; Eileen M Shore; Frederick S Kaplan Journal: J Bone Joint Surg Am Date: 2008-02 Impact factor: 5.284
Authors: Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore Journal: Best Pract Res Clin Rheumatol Date: 2008-03 Impact factor: 4.098
Authors: Enrice I Huenerfauth; Viktor Molnár; Marco Rosati; Malgorzata Ciurkiewicz; Franz J Söbbeler; Oliver Harms; Robert Hildebrandt; Wolfgang Baumgärtner; Andrea Tipold; Holger A Volk; Jasmin Nessler Journal: Front Vet Sci Date: 2022-07-04
Authors: Bernard J Smilde; Esmée Botman; Ruben D de Ruiter; Jan Maerten Smit; Berend P Teunissen; Wouter D Lubbers; Lothar A Schwarte; Patrick Schober; E Marelise W Eekhoff Journal: Orthop Res Rev Date: 2022-04-20
Authors: Edward C Hsiao; Maja Di Rocco; Amanda Cali; Michael Zasloff; Mona Al Mukaddam; Robert J Pignolo; Zvi Grunwald; Coen Netelenbos; Richard Keen; Genevieve Baujat; Matthew A Brown; Tae-Joon Cho; Carmen De Cunto; Patricia Delai; Nobuhiko Haga; Rolf Morhart; Christiaan Scott; Keqin Zhang; Robert J Diecidue; Clive S Friedman; Fredrick S Kaplan; Elisabeth M W Eekhoff Journal: Br J Clin Pharmacol Date: 2018-11-06 Impact factor: 4.335